MENU
DBVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
DBV Technologies S.A (DBVT) Ownership - Who owns DBV Technologies S.A?
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
177-181 avenue Pierre Brossolette
Phone
+33 155427878
Employees
104
Web
http://www.dbvtechnologies.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
217.64M
P/E Ratio
N/A
Total Cash
12.96M
Projected Growth
N/A
Total Debt
7.51M
Revenue
N/A
Risk (Beta)
-1.64
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
DBVT
Capitalization
218M
P/E Ratio
N/A
Risk (Beta)
-1.64
Dividend Yield
N/A
Total Cash
13M
Total Cash/Share
0.47
Total Debt
7.51M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
2.87M
P/B Ratio
81.97
Cash Flow
N/A
Earnings
-5.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11.7M
Current Ratio
0.72
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-107.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-115.70
Shares Held By Institutions
8.39M
Shares Outstanding - Current
27.4M
Total Liabilities
47.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
177.994
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of non invasive epicutaneous diagnostics systems and immunotherapy for allergy diagnostics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
177-181 avenue Pierre Brossolette
Phone
+33 155427878
Employees
104
Web
http://www.dbvtechnologies.com